These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36822878)

  • 21. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
    Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
    Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease.
    Li CH; Chen TF; Peng PL; Lin CH
    J Neurol; 2022 Dec; 269(12):6530-6543. PubMed ID: 35965282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
    Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
    Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
    J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary Microbiota Is Associated with Cognitive Impairment in Parkinson's Disease Patients.
    Arikan M; Yildiz Z; Kahraman Demir T; Yilmaz NH; Sen A; Hanoglu L; Yildirim S
    Microbiol Spectr; 2022 Feb; 10(1):e0235821. PubMed ID: 35138147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDD-5S: A useful screening tool for Parkinson's disease dementia.
    Lee WJ; Wu SL; Li JY; Chen CC; Lin JJ; Peng GS; Lin TK; Wang SJ; Chen RS; Yang YH; Tsai CH; Hsu JL; Liao YC; Chen SP; Fuh JL
    Parkinsonism Relat Disord; 2016 Apr; 25():85-90. PubMed ID: 26872691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An SBM-based machine learning model for identifying mild cognitive impairment in patients with Parkinson's disease.
    Zhang J; Li Y; Gao Y; Hu J; Huang B; Rong S; Chen J; Zhang Y; Wang L; Feng S; Wang L; Nie K
    J Neurol Sci; 2020 Nov; 418():117077. PubMed ID: 32798842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Progression to Parkinson's Disease Dementia Using Multivariate Normative Comparisons.
    Agelink van Rentergem JA; de Vent NR; Huizenga HM; Murre JMJ; ; Schmand BA
    J Int Neuropsychol Soc; 2019 Aug; 25(7):678-687. PubMed ID: 31084642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine learning trained with quantitative susceptibility mapping to detect mild cognitive impairment in Parkinson's disease.
    Shibata H; Uchida Y; Inui S; Kan H; Sakurai K; Oishi N; Ueki Y; Oishi K; Matsukawa N
    Parkinsonism Relat Disord; 2022 Jan; 94():104-110. PubMed ID: 34906915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Symbol-Digit Modalities Test in Mild Cognitive Impairment: Evidence from Parkinson's Disease Patients.
    Pascoe M; Alamri Y; Dalrymple-Alford J; Anderson T; MacAskill M
    Eur Neurol; 2018; 79(3-4):206-210. PubMed ID: 29597229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saccade, Pupil, and Blink Responses in Rapid Eye Movement Sleep Behavior Disorder.
    Perkins JE; Janzen A; Bernhard FP; Wilhelm K; Brien DC; Huang J; Coe BC; Vadasz D; Mayer G; Munoz DP; Oertel WH
    Mov Disord; 2021 Jul; 36(7):1720-1726. PubMed ID: 33754406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia.
    Matteau E; Dupré N; Langlois M; Provencher P; Simard M
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):100-6. PubMed ID: 22689702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.